Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Mini-Review Article

Protective Effect of Statin Therapy in Ankylosing Spondylitis

Author(s): Fataneh Tavasolian, Elham Abdollahi, Robert D. Inman* and Amirhossein Sahebkar*

Volume 20, Issue 1, 2025

Published on: 23 January, 2024

Page: [1 - 7] Pages: 7

DOI: 10.2174/0115748855272102231205111945

Price: $65

Open Access Journals Promotions 2
Abstract

Ankylosing spondylitis (AS) is a complex autoimmune and auto-inflammatory disorder characterized by a gradual onset that can progress to spinal ankylosis over time. This chronic condition primarily affects the sacroiliac joints and the spine, often extending its influence to peripheral joints and extra-articular organs, including the eyes AS is associated with significant disability, along with comorbidities such as uveitis and inflammatory bowel disease. Moreover, individuals with AS face an elevated risk of mortality due to cardiovascular disease (CVD). This paper explores the potential benefits of statins, known for their anti-inflammatory and immunomodulatory effects, in mitigating AS-related cardiovascular risk and their therapeutic effects on disease activity.

Keywords: Ankylosing spondylitis, inflammatory disease, mortality, cardiovascular disease, immunomodulatory effects, statins.

Next »
Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy